Pei Yee Tiew

Dr. Pei Yee Tiew


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2017 in Respirology
Verified
Journal Article
Closed access
PDF file
JLJanice M. Leung
Janice M. Leung
PTPei Yee Tiew
Pei Yee Tiew
MAMicheál Mac Aogáin
Micheál Mac Aogáin
KBKurtis F. Budden
Kurtis F. Budden
VYV. Wee Yong
V. Wee Yong
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall

1 August 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
MAMicheál Mac Aogáin
Micheál Mac Aogáin
KLKenny J. X. Lau
Kenny J. X. Lau
ZCZhao Cai
Zhao Cai
JNJayanth Kumar Narayana
Jayanth Kumar Narayana
RPRikky W. Purbojati
Rikky W. Purbojati
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
Rationale: Long-term antibiotic use for managing chronic respiratory disease is increasing; however, the role of the airway resistome and its relationship to host microbiomes remains unknown. Objectives: To evaluate airway resistomes and relate them to host and environmental microbiomes using ultradeep metagenomic shotgun sequencing. Methods: Airway specimens from 85 individuals with and without chronic respiratory disease (severe asthma, chronic obstructive pulmonary disease, and bronchiectasis) were subjected to metagenomic sequencing to an average depth exceeding 20 million reads. Respiratory and device-associated microbiomes were evaluated on the basis of taxonomical classification and functional annotation including the Comprehensive Antibiotic Resistance Database to determine airway resistomes. Co-occurrence networks of gene–microbe association were constructed to determine potential microbial sources of the airway resistome. Paired patient-inhaler metagenomes were compared (n = 31) to assess for the presence of airway–environment overlap in microbiomes and/or resistomes. Measurements and Main Results: Airway metagenomes exhibit taxonomic and metabolic diversity and distinct antimicrobial resistance patterns. A “core” airway resistome dominated by macrolide but with high prevalence of β-lactam, fluoroquinolone, and tetracycline resistance genes exists and is independent of disease status or antibiotic exposure. Streptococcus and Actinomyces are key potential microbial reservoirs of macrolide resistance including the ermX, ermF, and msrD genes. Significant patient-inhaler overlap in airway microbiomes and their resistomes is identified where the latter may be a proxy for airway microbiome assessment in chronic respiratory disease. Conclusions: Metagenomic analysis of the airway reveals a core macrolide resistome harbored by the host microbiome.

5 May 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
PTPei Yee Tiew
Pei Yee Tiew
KTKai Xian Thng
Kai Xian Thng
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
Pulmonary mycoses remain a global threat, causing significant morbidity and mortality. Patients with airways disease, including COPD and bronchiectasis, are at increased risks of pulmonary mycoses and its associated complications. Frequent use of antibiotics and corticosteroids coupled with impaired host defenses predispose patients to fungal colonization and airway persistence, which are associated with negative clinical consequences. Notably, Aspergillus species remain the best-studied fungal pathogen and induce a broad spectrum of clinical manifestations in COPD and bronchiectasis ranging from colonization and sensitization to more invasive disease. Next-generation sequencing (NGS) has gained prominence in the field of respiratory infection, and in some cases is beginning to act as a viable alternative to traditional culture. NGS has revolutionized our understanding of airway microbiota and in particular fungi. In this context, it permits the identification of the previously unculturable, fungal composition, and dynamic change within microbial communities of the airway, including potential roles in chronic respiratory disease. Furthermore, inter-kingdom microbial interactions, including fungi, in conjunction with host immunity have recently been shown to have important clinical roles in COPD and bronchiectasis. In this review, we provide an overview of clinical Aspergillus signatures in COPD and bronchiectasis and cover the current advances in the understanding of the mycobiome in these disease states. The challenges and limitations of NGS will be addressed.

Verified
Journal Article
Open access
PDF file
PTPei Yee Tiew
Pei Yee Tiew
OMOliver Meldrum
Oliver Meldrum
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
Microbiomics have significantly advanced over the last decade, driven by the widespread availability of next-generation sequencing (NGS) and multi-omic technologies. Integration of NGS and multi-omic datasets allow for a holistic assessment of endophenotypes across a range of chronic respiratory disease states, including chronic obstructive pulmonary disease (COPD). Valuable insight has been attained into the nature, function, and significance of microbial communities in disease onset, progression, prognosis, and response to treatment in COPD. Moving beyond single-biome assessment, there now exists a growing literature on functional assessment and host–microbe interaction and, in particular, their contribution to disease progression, severity, and outcome. Identifying specific microbes and/or metabolic signatures associated with COPD can open novel avenues for therapeutic intervention and prognosis-related biomarkers. Despite the promise and potential of these approaches, the large amount of data generated by such technologies can be challenging to analyze and interpret, and currently, there remains a lack of standardized methods to address this. This review outlines the current use and proposes future avenues for the application of NGS and multi-omic technologies in the endophenotyping, prognostication, and treatment of COPD.

1 February 2016 in Singapore Medical Journal
Verified
Journal Article
Closed access
VPV Poulose
V Poulose
PTPei Yee Tiew
Pei Yee Tiew
CHCh How
Ch How
Formed in 1959, the Singapore Medical Association (SMA) is the national medical organisation representing the majority of medical practitioners in both the public and private sectors

2 December 2024 in Respirology
Verified
Journal Article
Closed access
FIFransiskus Xaverius Ivan
Fransiskus Xaverius Ivan
PTPei Yee Tiew
Pei Yee Tiew
TJTavleen Kaur Jaggi
Tavleen Kaur Jaggi
KTKai Xian Thng
Kai Xian Thng
PPPee Hwee Pang
Pee Hwee Pang
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall